Skip to main content
Cancer Explained
Donate
Beginner 7 min readSource checked

Night Shift Work and Cancer

How night shift work may affect cancer risk through circadian disruption, which four cancer sites the evidence covers, and what a Group 2A label does and does not mean — based on IARC Monographs Volume 124.

Source

IARC Monographs Volume 124 — Night Shift Work

A family of four, two parents and two children, walk together outdoors on a sunny day
A family of four, two parents and two children, walk together outdoors on a sunny day

Key fact

Night shift work is classified as a probable human carcinogen (IARC Group 2A).

The short answer

IARC classifies night shift work as probably carcinogenic to humans (Group 2A), based on limited human evidence covering cancers of the breast, prostate, colon, and rectum, plus sufficient animal evidence for altered light-dark schedules. A decade of new studies left that classification unchanged, and IARC did not estimate how large the risk is.

  • Night shift work is classified as a probable human carcinogen (IARC Group 2A).

  • People are mainly exposed by long-term night or rotating shift work that disrupts the body clock.

  • The human evidence, graded limited, covers positive associations with cancers of the breast, prostate, colon, and rectum.

  • A carcinogen classification describes hazard — whether something can cause cancer — not your personal risk at a given exposure.

Choose how you want to understand this

The full explanation.

What exactly got evaluated

In June 2019, 27 independent experts from 16 countries met in Lyon, France. They worked for eight days. Their assignment was odd for the IARC Monographs programme. Most entries in that programme are chemicals. This one was a work schedule.

The agent arrived at the meeting under a clumsy name: "shift work that involves circadian disruption." The Working Group renamed it night shift work. The new name better matched the real exposure, and the studies that actually exist.

Their definition is precise and worth quoting. It is work during the regular sleeping hours of the general population. Two things follow from that wording. First, the exposure is defined by the clash with that sleep window, not by the job title. Second, the definition takes in transmeridian air travel. That means flying fast across many time zones, as cockpit and cabin crew do.

The 2019 verdict, and the one it replaced

The conclusion: night shift work is probably carcinogenic to humans, Group 2A.

That is not a change. An IARC Working Group reached the same classification in 2007. It was published as Volume 98 in 2010. So why meet again? Because a great many new studies appeared in the decade that followed. An IARC advisory group convened in 2014 gave shift work high priority for re-evaluation between 2015 and 2019. The full assessment is Volume 124.

Group 2A has a technical definition, and it explains the whole document. The category is used in one situation. There is limited evidence of cancer in humans, plus sufficient evidence in experimental animals. "Limited" is a term of art here. It means a positive link between exposure and cancer has been seen. But chance, bias, and confounding could not be ruled out as explanations.

Four cancer sites, and why the evidence stayed "limited"

The Working Group reviewed four separate kinds of data. Where and how people are exposed to night shift work. Studies of cancer in exposed people. Studies of cancer in laboratory animals exposed to altered light–dark schedules. And studies of the mechanisms by which the exposure might act.

Four cancer sites had the most information behind them: breast, prostate, colon, and rectum. Positive links were seen at all four. Some studies covered specific worker groups, such as nurses, factory workers, and airplane cabin and cockpit crew. Others drew on the general population, covering anyone who had held a job with night work.

Then comes the sentence that many summaries skip. Some large, informative studies found no link between night shift work and breast cancer, or any other cancer type. Other large, informative studies did find one. The Working Group's explanation is about method. The new studies used many different ways to measure night shift exposure, some better than others. So the group concluded that a positive link exists overall for breast, prostate, colon, and rectal cancer. It also concluded that bias could not be ruled out with reasonable confidence.

That is an honest description of a real state of knowledge. It is neither reassurance nor alarm.

What the animal and mechanism work adds

The evidence in laboratory animals is graded sufficient, the stronger term. What was tested there was not a shift roster. It was the underlying exposure: alteration in the light–dark schedule.

The mechanistic evidence was rated strong in experimental systems. IARC named the three effects it rested on. Immunosuppression, meaning a weakened immune response. Chronic inflammation. And increased cell proliferation, meaning more cell division. Those three show up across many carcinogens. Finding them here is what let a limited human signal combine with animal data into a 2A.

The most pronounced effect of night shift work is the disruption of circadian rhythms. Those are the daily cycles that govern normal body function. IARC is careful on the last step. It says plainly that it is unknown to what extent those disruptions lead to cancer.

How many people this covers

About 20% of workers in North America, Europe, and elsewhere work outside the standard daytime shift. Some sectors run far higher. Manufacturing, medical work, retail, services including information technology, and transportation all do.

Some of that work happens in one place: a factory, a restaurant, a hospital ward. Some happens on an aircraft crossing time zones. Night shift work is how production and services continue 24 hours a day, seven days a week. That is why this exposure will be managed rather than eliminated.

What a Group 2A label does not tell you

IARC classifies hazards, not risks. A hazard is the ability to cause cancer under some circumstances. Risk is the chance that cancer will actually occur at a given level of exposure. The Working Group did not try to estimate risk at different amounts of night shift work. That would take a separate risk assessment, which is not what the Monographs do.

Two agents in the same group can carry very different real-world risk. The type and extent of exposure differ. So does the size of the effect at a given exposure level. IARC makes this point bluntly in its own Q&A for this volume. The classification puts night shift work in the same category as working as a hairdresser or barber. And it says directly that exposures sharing a category are not therefore equally dangerous. Our page on hazard versus risk works through that distinction, and how the IARC monographs work covers how the categories are assigned.

IARC also declines two things people often expect from it. It does not make recommendations about what an individual should do after exposure to a possible carcinogen. Its Q&A suggests consulting a physician instead. It also does not recommend regulations or legislation. Those remain the responsibility of national governments, though health and regulatory agencies do use Monographs evaluations when deciding what to do.

The practical residue

For someone who has worked nights for years, the useful conclusions from Volume 124 are narrow but real.

The four cancer sites named are the ones worth raising with a clinician. Three of them have established screening pathways that apply to the general population anyway. Screening schedules for breast, colon, and rectal cancer do not change because of shift work. But a night roster is a common reason people fall behind on appointments, and that part is fixable. See breast cancer and colorectal cancer for what those pathways involve.

The exposure tested in animals was light at the wrong time, not tiredness. That is worth knowing. It points at lighting, sleep timing, and shift rotation patterns as the things under study, rather than at effort or fatigue.

And the honest headline is this. A decade of new research left the classification exactly where it was in 2007. More studies did not settle the question. They mapped it more carefully.

Sources

Words to know

Tap any term to see what it means.

Browse the full glossary →

Bouquets of flowers and lit candles arranged at the base of a large tree in a park, with a small group of people out of focus behind.

Common questions

Does night shift work cause cancer?

Probably. Night shift work is classified as a probable human carcinogen: the evidence in people is limited, but animal and laboratory studies support a link. "Probable" means suspected on solid grounds, not proven.

How are people exposed to night shift work?

Most exposure happens by long-term night or rotating shift work that disrupts the body clock.

Which cancers are linked to night shift work?

IARC's Working Group found positive associations with cancers of the breast, prostate, colon, and rectum. It graded that human evidence as limited, meaning bias could not be ruled out. Some large studies found no association at all, and IARC did not estimate how much risk any given amount of night work carries.

How can I reduce my exposure to night shift work?

The main steps are protecting sleep and keeping up with screening.

Does a carcinogen label mean I will get cancer?

No. A classification is about hazard — whether night shift work can cause cancer under some conditions — not a prediction that any one exposed person will develop cancer. Your actual risk depends on the amount and length of exposure and other factors.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Knowledge Check

0 of 3 answered

  1. Q1.How do health agencies classify night shift work?
  2. Q2.According to this article, how are people most often exposed to night shift work?
  3. Q3.Night shift work is most strongly linked to which cancer?

This self-assessment checks understanding of educational content only. It is not medical advice.

Prepared by Cancer Explained's AI-assisted editorial system

Written from IARC Monographs Volume 124 — Night Shift Work material and checked line by line against the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Last updated: 2026-08-06Next planned review: 2028-07-05

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.